Published in
Wiley Open Access, Clinical Case Reports, 12(7), p. 2500-2504, 2019
DOI: 10.1002/ccr3.2543
Links
Tools
Alectinib, an anaplastic lymphoma kinase (ALK) inhibitor, as a bridge to allogeneic stem cell transplantation in a patient with ALK‐positive anaplastic large‐cell lymphoma refractory to chemotherapy and brentuximab vedotin
Journal article published in 2019 by
Ritsuko Nakai,
Suguru Fukuhara 
,
Akiko Miyagi Maeshima ,
Sung‐Won Kim,
Yuta Ito,
Shunsuke Hatta,
Tomotaka Suzuki,
Sayako Yuda ,
Shinichi Makita ,
Wataru Munakata ,
Tatsuya Suzuki,
Dai Maruyama ,
Koji Izutsu
,
Akiko Miyagi Maeshima ,
Sung‐Won Kim,
Yuta Ito,
Shunsuke Hatta,
Tomotaka Suzuki,
Sayako Yuda ,
Shinichi Makita ,
Wataru Munakata ,
Tatsuya Suzuki,
Dai Maruyama ,
Koji Izutsu
This paper is made freely available by the publisher.
Full text: Download
Data provided by 